Pharmaceutical Technology

News, views and contacts from the global Pharmaceutical industry
14 December 2018
WEEKLY UPDATE
Digital Magazine
Latest Companies

Nymi™

HOF Sonderanlagenbau

Emisphere Technologies

CEPHA

Distek

Pharmaceutical Technology on Facebook

Join Pharmaceutical Technology on Facebook!
We're on Facebook and we'd like you to join us there too. Now there's a new way to keep up on our biggest stories, breaking news and exclusive content. Become a fan of Pharmaceutical Technology on Facebook and click the 'like' button. Simple as that!

White Papers

Trehalose: A Powerful Excipient in the Formulation Toolbox
In the pharmaceutical industry, products that benefit from the stabilising effects of trehalose include, but are not limited to, monoclonal antibodies (mAbs), antibody drug conjugates (ADCs), fusion proteins, peptides, stem cells and vaccines.

Monomaterial Packaging Benefits
In February 2108, a young sperm whale washed up on a beach in southeastern Spain. When scientists carried out a necropsy, they discovered the huge mammal had succumbed to a fatal infection caused by more than 30 kilos of plastics in its stomach and intestines.

Why Did My Plant Close?
Global vice-president of pharma biotech and medical devices at NSF Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.

Aqueous Cleaning in Pharmaceutical Manufacturing
The use of aqueous cleaning in pharmaceutical manufacturing can provide numerous benefits in terms of effectiveness, minimal surface residue, and easier cleaning validation.

Qualification of Powdered Gelatin Agar by NIR Spectroscopy
Agar is a mixture of polysaccharides widely used in food, chemical and pharmaceutical industries for its jelly-like structure. 

Press Releases

Distek’s PrepEngine Mini Sample Prep Station
Distek’s PrepEngine Mini Sample Prep Station is designed for assay, impurity and content uniformity applications.

Alkaline Soak for Tough Biologic Residues
Alkaline hydrolysis is a chemical reaction that takes place when tough organic residues are exposed to an alkaline solution. Alkaline hydrolysis breaks these residues into smaller more water-soluble and more easily emulsified molecules.

Gerteis to Attend PMEC in Delhi, India
This year's PMEC event has opened in Noida, Delhi, India.

Webinar: Reckoning With Risk
From the moment we get out of bed in the morning to when we return at night, we all take risks. Some big, others small. Some consciously, others less so. There is no such thing as zero risk.

Sanitary Sieves for Medicinal Powders
Sri Krishna Pharmaceuticals is an established manufacturer of pharmaceutical products such as acetaminophen (paracetamol), folic acid, domperidone and furosemide, supplying more than 150 niche drugs to the Asian pharmaceutical market, Europe and the US.

Features

Can blockchain stem the tide of counterfeit drugs in India?
Counterfeit drugs are a multi-billion dollar problem. Now pharma companies are looking for a technological solution, could blockchain be the answer?

Brexit’s impact on UK life sciences: some key points
After Brexit, the impact on the life sciences and healthcare sectors is largely dependent on what model the UK adopts for its relationship with the EU.

Janssen’s Tremfya shows superiority in plaque psoriasis to Novartis’ drug at 48 weeks
Johnson & Johnson subsidiary Janssen has announced results from its phase III Eclipse trial comparing its Tremfya (guselkumab) with Novartis’ Cosentyx (secukinumab) in adults with moderate to severe plaque psoriasis.

Lilly teams up with AC Immune for Alzheimer’s drug
Eli Lilly has signed a licence and collaboration agreement with Swiss biotech AC Immune for the research and development of tau aggregation inhibitor small molecules to treat neurodegenerative disorders, including Alzheimer’s disease.

Incretin combination therapy: a breakthrough for type 2 diabetes?
With unmet needs remaining in type 2 diabetes, pharmaceutical companies are becoming more experimental when developing new treatments. One trend includes combining drugs in one class to determine if they are more efficacious than one drug alone. This trend has been applied to incretins, GLP-1 and GIP, with Eli Lilly recently publishing positive results for its drug candidate LY3298176.

Projects

Knight Cancer Institute Research Building, Oregon
Oregon Health & Science University’s (OHSU) Knight Cancer Institute built a new research building at South Waterfront district in south-west Portland, Oregon, US.

Seqirus Vaccine Manufacturing Facility Expansion, Holly Springs, US
Seqirus, a biotherapeutics company based in Australia, announced plans to expand its flu vaccine manufacturing facility located in Holly Springs, North Carolina, US, in November 2018.

Abzena’s Biotherapeutics Manufacturing Facility Relocation, San Diego
Abzena is expanding its biotherapeutics manufacturing operations by relocating to a new leased facility in Lusk Boulevard, San Diego, US.

Astellas Institute for Regenerative Medicine Relocation
Japanese pharmaceutical company Astellas Pharma has announced plans to relocate its wholly-owned US subsidiary Astellas Institute for Regenerative Medicine (AIRM) in December 2017.

Medicago’s Vaccine Production Facility, Quebec, Canada
Medicago is constructing a new influenza vaccine production facility in the Estimauville Innovation Area in Quebec City, Canada.

Follow Us:   Facebook Facebook    Twitter Twitter   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Pharmaceutical Technology or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties.

www.pharmaceutical-technology.com is a product of Kable.
Copyright
2018 Kable, a trading division of Kable Intelligence Limited.